We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Quality Assurance in IVT RNA Vaccine Development

Quality Assurance in IVT RNA Vaccine Development content piece image

Quality Assurance in In Vitro Transcribed RNA Vaccine Development Using Agilent Automated Electrophoresis Instruments

As infectious diseases spread rapidly across the world, there is an urgent need for swift development and distribution of vaccines.

In vitro transcribed (IVT) RNA vaccines are highly adaptable, efficient and ideally suited for fast production, so have emerged as a valuable tool against infectious diseases. However, as the number of vaccine targets and production goals increase, so does the need for robust, reliable and rapid quality control methods.

Download this whitepaper to learn more about: 

  • Vaccine development
  • Vaccine production
  • Quality assurance in mRNA vaccine production